MESO:NASDAQ
Mesoblast Ltd
13,27 $
arrow_upward
+1,30%(+0,17) 1D
13 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MESO...
Open
13,13 $
High
13,28 $
Low
12,88 $
Mkt. cap
1,75 մլրդ
Avg. vol.
276,86 հզր
Volume
347,02 հզր
52-wk high
21,50 $
52-wk low
11,89 $
EPS
-0,44 $
Beta
2,21
Shares outstanding
130,13 մլն
No. of employees
108
Open
13,13 $
High
13,28 $
Low
12,88 $
Mkt. cap
1,75 մլրդ
Avg. vol.
276,86 հզր
Volume
347,02 հզր
52-wk high
21,50 $
52-wk low
11,89 $
EPS
-0,44 $
Beta
2,21
Shares outstanding
130,13 մլն
No. of employees
108
News stories
From web sources and news partners
TradingView
·
5 ժամ առաջ
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
24/7 Wall St.
·
1 ժամ առաջ
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Bloomberg.com
·
10 ժամ առաջ
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd